Cognition Therapeutics
CGTX
CGTX
34 hedge funds and large institutions have $10.1M invested in Cognition Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $13.9M → $10.1M (-$3.79M)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.6M | |
| 2 | +$633K | |
| 3 | +$397K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$302K |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$273K |
Top Sellers
| 1 | -$190K | |
| 2 | -$110K | |
| 3 | -$95K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$80.7K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$62.4K |